Global Oligonucleotide API Market Research Report 2020
Table of Contents1 Oligonucleotide API Market Overview
1.1 Product Overview and Scope of Oligonucleotide API
1.2 Oligonucleotide API Segment by Type
1.2.1 Global Oligonucleotide API Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Antisense Oligonucleotides API
1.2.3 Small Interfering RNA (siRNA) API
1.2.4 MiRNA API
1.2.5 CpG Oligonucleotides API
1.2.6 Others
1.3 Oligonucleotide API Segment by Application
1.3.1 Oligonucleotide API Sales Comparison by Application: 2020 VS 2026
1.3.2 Contract Manufacturing Organizations (CMOs)
1.3.3 Pharmaceutical Companies
1.4 Global Oligonucleotide API Market Size Estimates and Forecasts
1.4.1 Global Oligonucleotide API Revenue 2015-2026
1.4.2 Global Oligonucleotide API Sales 2015-2026
1.4.3 Oligonucleotide API Market Size by Region: 2020 Versus 2026
1.5 Oligonucleotide API Industry
1.6 Oligonucleotide API Market Trends
2 Global Oligonucleotide API Market Competition by Manufacturers
2.1 Global Oligonucleotide API Sales Market Share by Manufacturers (2015-2020)
2.2 Global Oligonucleotide API Revenue Share by Manufacturers (2015-2020)
2.3 Global Oligonucleotide API Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Oligonucleotide API Manufacturing Sites, Area Served, Product Type
2.5 Oligonucleotide API Market Competitive Situation and Trends
2.5.1 Oligonucleotide API Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Oligonucleotide API Players (Opinion Leaders)
3 Oligonucleotide API Retrospective Market Scenario by Region
3.1 Global Oligonucleotide API Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Oligonucleotide API Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Oligonucleotide API Market Facts & Figures by Country
3.3.1 North America Oligonucleotide API Sales by Country
3.3.2 North America Oligonucleotide API Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oligonucleotide API Market Facts & Figures by Country
3.4.1 Europe Oligonucleotide API Sales by Country
3.4.2 Europe Oligonucleotide API Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oligonucleotide API Market Facts & Figures by Region
3.5.1 Asia Pacific Oligonucleotide API Sales by Region
3.5.2 Asia Pacific Oligonucleotide API Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oligonucleotide API Market Facts & Figures by Country
3.6.1 Latin America Oligonucleotide API Sales by Country
3.6.2 Latin America Oligonucleotide API Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Oligonucleotide API Market Facts & Figures by Country
3.7.1 Middle East and Africa Oligonucleotide API Sales by Country
3.7.2 Middle East and Africa Oligonucleotide API Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Oligonucleotide API Historic Market Analysis by Type
4.1 Global Oligonucleotide API Sales Market Share by Type (2015-2020)
4.2 Global Oligonucleotide API Revenue Market Share by Type (2015-2020)
4.3 Global Oligonucleotide API Price Market Share by Type (2015-2020)
4.4 Global Oligonucleotide API Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Oligonucleotide API Historic Market Analysis by Application
5.1 Global Oligonucleotide API Sales Market Share by Application (2015-2020)
5.2 Global Oligonucleotide API Revenue Market Share by Application (2015-2020)
5.3 Global Oligonucleotide API Price by Application (2015-2020)
6 Company Profiles and Key Figures in Oligonucleotide API Business
6.1 Jazz Pharmaceuticals
6.1.1 Corporation Information
6.1.2 Jazz Pharmaceuticals Description, Business Overview and Total Revenue
6.1.3 Jazz Pharmaceuticals Oligonucleotide API Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Jazz Pharmaceuticals Products Offered
6.1.5 Jazz Pharmaceuticals Recent Development
6.2 Sarepta Therapeutics
6.2.1 Sarepta Therapeutics Corporation Information
6.2.2 Sarepta Therapeutics Description, Business Overview and Total Revenue
6.2.3 Sarepta Therapeutics Oligonucleotide API Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Sarepta Therapeutics Products Offered
6.2.5 Sarepta Therapeutics Recent Development
6.3 Biogen
6.3.1 Biogen Corporation Information
6.3.2 Biogen Description, Business Overview and Total Revenue
6.3.3 Biogen Oligonucleotide API Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Biogen Products Offered
6.3.5 Biogen Recent Development
6.4 Dynavax Technologies
6.4.1 Dynavax Technologies Corporation Information
6.4.2 Dynavax Technologies Description, Business Overview and Total Revenue
6.4.3 Dynavax Technologies Oligonucleotide API Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Dynavax Technologies Products Offered
6.4.5 Dynavax Technologies Recent Development
6.5 Akcea Therapeutics
6.5.1 Akcea Therapeutics Corporation Information
6.5.2 Akcea Therapeutics Description, Business Overview and Total Revenue
6.5.3 Akcea Therapeutics Oligonucleotide API Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Akcea Therapeutics Products Offered
6.5.5 Akcea Therapeutics Recent Development
6.6 Alnylam Pharmaceuticals
6.6.1 Alnylam Pharmaceuticals Corporation Information
6.6.2 Alnylam Pharmaceuticals Description, Business Overview and Total Revenue
6.6.3 Alnylam Pharmaceuticals Oligonucleotide API Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Alnylam Pharmaceuticals Products Offered
6.6.5 Alnylam Pharmaceuticals Recent Development
6.7 Nitto Denko (Avecia)
6.6.1 Nitto Denko (Avecia) Corporation Information
6.6.2 Nitto Denko (Avecia) Description, Business Overview and Total Revenue
6.6.3 Nitto Denko (Avecia) Oligonucleotide API Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Nitto Denko (Avecia) Products Offered
6.7.5 Nitto Denko (Avecia) Recent Development
6.8 Ajinomoto (GeneDesign)
6.8.1 Ajinomoto (GeneDesign) Corporation Information
6.8.2 Ajinomoto (GeneDesign) Description, Business Overview and Total Revenue
6.8.3 Ajinomoto (GeneDesign) Oligonucleotide API Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Ajinomoto (GeneDesign) Products Offered
6.8.5 Ajinomoto (GeneDesign) Recent Development
6.9 RiboBio
6.9.1 RiboBio Corporation Information
6.9.2 RiboBio Description, Business Overview and Total Revenue
6.9.3 RiboBio Oligonucleotide API Sales, Revenue and Gross Margin (2015-2020)
6.9.4 RiboBio Products Offered
6.9.5 RiboBio Recent Development
7 Oligonucleotide API Manufacturing Cost Analysis
7.1 Oligonucleotide API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oligonucleotide API
7.4 Oligonucleotide API Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oligonucleotide API Distributors List
8.3 Oligonucleotide API Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Oligonucleotide API Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oligonucleotide API by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Oligonucleotide API by Type (2021-2026)
10.2 Oligonucleotide API Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oligonucleotide API by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Oligonucleotide API by Application (2021-2026)
10.3 Oligonucleotide API Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oligonucleotide API by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Oligonucleotide API by Region (2021-2026)
10.4 North America Oligonucleotide API Estimates and Projections (2021-2026)
10.5 Europe Oligonucleotide API Estimates and Projections (2021-2026)
10.6 Asia Pacific Oligonucleotide API Estimates and Projections (2021-2026)
10.7 Latin America Oligonucleotide API Estimates and Projections (2021-2026)
10.8 Middle East and Africa Oligonucleotide API Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Oligonucleotide API Sales (Ton) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Oligonucleotide API Sales (Ton) Comparison by Application: 2020 VS 2026
Table 3. Global Oligonucleotide API Market Size by Type (Ton) (US$ Million) (2020 VS 2026)
Table 4. Global Key Oligonucleotide API Manufacturers Covered in This Study
Table 5. Global Oligonucleotide API Sales (Ton) by Manufacturers (2015-2020)
Table 6. Global Oligonucleotide API Sales Share by Manufacturers (2015-2020)
Table 7. Global Oligonucleotide API Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Oligonucleotide API Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Oligonucleotide API Average Price (US$/Ton) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Oligonucleotide API Sales Sites and Area Served
Table 11. Manufacturers Oligonucleotide API Product Types
Table 12. Global Oligonucleotide API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oligonucleotide API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide API as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Oligonucleotide API Players
Table 16. Global Oligonucleotide API Sales (Ton) by Region (2015-2020)
Table 17. Global Oligonucleotide API Sales Market Share by Region (2015-2020)
Table 18. Global Oligonucleotide API Revenue (Million US$) by Region (2015-2020)
Table 19. Global Oligonucleotide API Revenue Market Share by Region (2015-2020)
Table 20. North America Oligonucleotide API Sales by Country (2015-2020) (Ton)
Table 21. North America Oligonucleotide API Sales Market Share by Country (2015-2020)
Table 22. North America Oligonucleotide API Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Oligonucleotide API Revenue Market Share by Country (2015-2020)
Table 24. Europe Oligonucleotide API Sales by Country (2015-2020) (Ton)
Table 25. Europe Oligonucleotide API Sales Market Share by Country (2015-2020)
Table 26. Europe Oligonucleotide API Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Oligonucleotide API Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Oligonucleotide API Sales by Region (2015-2020) (Ton)
Table 29. Asia Pacific Oligonucleotide API Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Oligonucleotide API Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Oligonucleotide API Revenue Market Share by Region (2015-2020)
Table 32. Latin America Oligonucleotide API Sales by Country (2015-2020) (Ton)
Table 33. Latin America Oligonucleotide API Sales Market Share by Country (2015-2020)
Table 34. Latin America Oligonucleotide API Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Oligonucleotide API Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Oligonucleotide API Sales by Country (2015-2020) (Ton)
Table 37. Middle East and Africa Oligonucleotide API Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Oligonucleotide API Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Oligonucleotide API Revenue Market Share by Country (2015-2020)
Table 40. Global Oligonucleotide API Sales (Ton) by Type (2015-2020)
Table 41. Global Oligonucleotide API Sales Share by Type (2015-2020)
Table 42. Global Oligonucleotide API Revenue (Million US$) by Type (2015-2020)
Table 43. Global Oligonucleotide API Revenue Share by Type (2015-2020)
Table 44. Global Oligonucleotide API Price (US$/Ton) by Type (2015-2020)
Table 45. Global Oligonucleotide API Sales (Ton) by Application (2015-2020)
Table 46. Global Oligonucleotide API Sales Market Share by Application (2015-2020)
Table 47. Global Oligonucleotide API Sales Growth Rate by Application (2015-2020)
Table 48. Jazz Pharmaceuticals Oligonucleotide API Corporation Information
Table 49. Jazz Pharmaceuticals Description and Business Overview
Table 50. Jazz Pharmaceuticals Oligonucleotide API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 51. Jazz Pharmaceuticals Main Product
Table 52. Jazz Pharmaceuticals Recent Development
Table 53. Sarepta Therapeutics Oligonucleotide API Corporation Information
Table 54. Sarepta Therapeutics Corporation Information
Table 55. Sarepta Therapeutics Oligonucleotide API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 56. Sarepta Therapeutics Main Product
Table 57. Sarepta Therapeutics Recent Development
Table 58. Biogen Oligonucleotide API Corporation Information
Table 59. Biogen Corporation Information
Table 60. Biogen Oligonucleotide API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 61. Biogen Main Product
Table 62. Biogen Recent Development
Table 63. Dynavax Technologies Oligonucleotide API Corporation Information
Table 64. Dynavax Technologies Corporation Information
Table 65. Dynavax Technologies Oligonucleotide API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 66. Dynavax Technologies Main Product
Table 67. Dynavax Technologies Recent Development
Table 68. Akcea Therapeutics Oligonucleotide API Corporation Information
Table 69. Akcea Therapeutics Corporation Information
Table 70. Akcea Therapeutics Oligonucleotide API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 71. Akcea Therapeutics Main Product
Table 72. Akcea Therapeutics Recent Development
Table 73. Alnylam Pharmaceuticals Oligonucleotide API Corporation Information
Table 74. Alnylam Pharmaceuticals Corporation Information
Table 75. Alnylam Pharmaceuticals Oligonucleotide API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 76. Alnylam Pharmaceuticals Main Product
Table 77. Alnylam Pharmaceuticals Recent Development
Table 78. Nitto Denko (Avecia) Oligonucleotide API Corporation Information
Table 79. Nitto Denko (Avecia) Corporation Information
Table 80. Nitto Denko (Avecia) Oligonucleotide API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 81. Nitto Denko (Avecia) Main Product
Table 82. Nitto Denko (Avecia) Recent Development
Table 83. Ajinomoto (GeneDesign) Oligonucleotide API Corporation Information
Table 84. Ajinomoto (GeneDesign) Corporation Information
Table 85. Ajinomoto (GeneDesign) Oligonucleotide API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 86. Ajinomoto (GeneDesign) Main Product
Table 87. Ajinomoto (GeneDesign) Recent Development
Table 88. RiboBio Oligonucleotide API Corporation Information
Table 89. RiboBio Corporation Information
Table 90. RiboBio Oligonucleotide API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 91. RiboBio Main Product
Table 92. RiboBio Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Oligonucleotide API Distributors List
Table 96. Oligonucleotide API Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Oligonucleotide API Sales (Ton) Forecast by Type (2021-2026)
Table 101. Global Oligonucleotide API Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Oligonucleotide API Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Oligonucleotide API Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Oligonucleotide API Sales (Ton) Forecast by Application (2021-2026)
Table 105. Global Oligonucleotide API Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Oligonucleotide API Sales (Ton) Forecast by Region (2021-2026)
Table 107. Global Oligonucleotide API Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Oligonucleotide API Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Oligonucleotide API Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of FiguresFigure 1. Picture of Oligonucleotide API
Figure 2. Global Oligonucleotide API Sales Market Share by Type: 2020 VS 2026
Figure 3. Antisense Oligonucleotides API Product Picture
Figure 4. Small Interfering RNA (siRNA) API Product Picture
Figure 5. MiRNA API Product Picture
Figure 6. CpG Oligonucleotides API Product Picture
Figure 7. Others Product Picture
Figure 8. Global Oligonucleotide API Consumption Market Share by Application: 2020 VS 2026
Figure 9. Contract Manufacturing Organizations (CMOs)
Figure 10. Pharmaceutical Companies
Figure 11. Global Oligonucleotide API Market Size 2015-2026 (US$ Million)
Figure 12. Global Oligonucleotide API Sales Capacity (Ton) (2015-2026)
Figure 13. Global Oligonucleotide API Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Oligonucleotide API Sales Share by Manufacturers in 2020
Figure 15. Global Oligonucleotide API Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Oligonucleotide API Revenue in 2019
Figure 17. Oligonucleotide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Oligonucleotide API Sales Market Share by Region (2015-2020)
Figure 19. Global Oligonucleotide API Sales Market Share by Region in 2019
Figure 20. Global Oligonucleotide API Revenue Market Share by Region (2015-2020)
Figure 21. Global Oligonucleotide API Revenue Market Share by Region in 2019
Figure 22. North America Oligonucleotide API Sales Market Share by Country in 2019
Figure 23. North America Oligonucleotide API Revenue Market Share by Country in 2019
Figure 24. U.S. Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 25. U.S. Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 27. Canada Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Oligonucleotide API Sales Market Share by Country in 2019
Figure 29. Europe Oligonucleotide API Revenue Market Share by Country in 2019
Figure 30. Germany Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 31. Germany Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 33. France Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 35. U.K. Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 37. Italy Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 39. Russia Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Oligonucleotide API Sales Market Share by Region in 2019
Figure 41. Asia Pacific Oligonucleotide API Revenue Market Share by Region in 2019
Figure 42. China Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 43. China Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 45. Japan Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 47. South Korea Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 49. India Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 51. Australia Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 53. Taiwan Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 55. Indonesia Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 57. Thailand Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 59. Malaysia Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 61. Philippines Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 63. Vietnam Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Oligonucleotide API Sales Market Share by Country in 2019
Figure 65. Latin America Oligonucleotide API Revenue Market Share by Country in 2019
Figure 66. Mexico Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 67. Mexico Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 69. Brazil Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 71. Argentina Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Oligonucleotide API Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Oligonucleotide API Revenue Market Share by Country in 2019
Figure 74. Turkey Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 75. Turkey Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 77. Saudi Arabia Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. UAE Oligonucleotide API Sales Growth Rate (2015-2020) (Ton)
Figure 79. UAE Oligonucleotide API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Oligonucleotide API by Type (2015-2020)
Figure 81. Sales Market Share of Oligonucleotide API by Type in 2019
Figure 82. Revenue Share of Oligonucleotide API by Type (2015-2020)
Figure 83. Revenue Market Share of Oligonucleotide API by Type in 2019
Figure 84. Global Oligonucleotide API Sales Growth by Type (2015-2020) (Ton)
Figure 85. Global Oligonucleotide API Sales Market Share by Application (2015-2020)
Figure 86. Global Oligonucleotide API Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Oligonucleotide API by Application (2015-2020)
Figure 88. Global Revenue Share of Oligonucleotide API by Application in 2020
Figure 89. Jazz Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Sarepta Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Dynavax Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Akcea Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Alnylam Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Nitto Denko (Avecia) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Ajinomoto (GeneDesign) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. RiboBio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Oligonucleotide API
Figure 100. Manufacturing Process Analysis of Oligonucleotide API
Figure 101. Oligonucleotide API Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Oligonucleotide API Sales (Ton) and Growth Rate Forecast (2021-2026)
Figure 106. North America Oligonucleotide API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Oligonucleotide API Sales (Ton) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Oligonucleotide API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Oligonucleotide API Sales (Ton) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Oligonucleotide API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Oligonucleotide API Sales (Ton) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Oligonucleotide API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Oligonucleotide API Sales (Ton) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Oligonucleotide API Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed